Abstract

Oxygenated derivatives of cholesterol are known to exhibit a number of biological activities including the inhibition of cholesterol biosynthesis and of cell proliferation, but their mechanism of action remains unclear. Previous studies have identified a cytosolic protein which binds 25-hydroxycholesterol, as well as several other oxysterols, with high affinity, possibly mediating some of their effects. We now report the existence of a high-affinity oxysterol binding site in rat liver microsomes which is distinct from the cytosolic binding protein. Among the oxygenated sterols examined, 5α-cholestan-3β-ol-7-one (7-katecholestanol) had the highest affinity for this microsomal binding site ( K d = 2.7 nM). Using 7-keto[ 3H]cholestanol as the radioactive ligand, we found that binding of this oxysterol to the microsomal binding site was saturable and reversible and was displaceable by the following oxysterols in descending order of potency: 7-ketocholestanol > 6-ketocholestanol > 7 β-hydroxycholesterol = 7-ketocholesterol > cholesten-3 β,5 α6 β-triol = 7 α-hydroxycholesterol > 4-cholesten-3-one. One other sterols studied, including, notably, 25-hydroxycholesterol, had little or no inhibitory effect on 7-keto[ 3H]cholestanol binding. Additional studies revealed that the microsomal oxysterol binding site was probably identical to the antiestrogen binding site described by other workers. First, saturation analysis and kinetic studies demonstrated that the antiestrogen tamoxifen competed directly with 7-keto[ 3H]cholestanol for the same binding site. Second, tha ability of different oxysterols and antiestrogens to inhibit 7-keto[ 3H]cholestanol binding to the microsomal binding site paralleled their ability to inhibit [ 3H]tamoxifen binding to the antiestrogen binding site. Third, the tissue distribution of binding sites for 7-keto[ 3H]cholestanol was similar to that antiestrogen binding site. We conclude that: (1) in rat liver microsomes there are high-affinity oxysterol binding sites whose ligand specificity is different from that of the cytosolic oxysterol binding protein; and (2) the microsomal oxysterol binding site is probably identical to the antiestrogen binding site. The biological significance of these observations remains to be explored.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call